CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

SAN DIEGO, March 2, 2023 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, announced today that CV…

Leave a Reply

Your email address will not be published. Required fields are marked *